baber/WOPTO huggingface dataset:
Patent AU-2793484-A (AU)
Title: Preheating copper concentrates
Inventor: BJORNBERG ARNE
IPC: C22B1/10
Filed: 1984-05-11
Abstract: The invention relates to a method for preparing a sui- phidic concentrate which is intended for further processing to copper and/or precious metals and which contains high percentages of arsenic and/or antimony, and possibly also bismuth in quantities likely to disturb subsequent processing stages, by partially roasting the concentrate in a fluidized bed, so as to eliminate substantially all the arsenic present and a major part of the antimony and/or bismuth. According to the invention, the concentrate and gas are supplied to a fluidized-bed reactor, and are there heated to a minimum temperature above the splitting or decomposition temperatures of the complex minerals containing arsenic and/or antimony and bismuth present in the concentrate. The oxygen potential in the reactor is regulated, so as to prevent the formation of non-volatile compounds of said impurities. The residence time of the concentrate in the reactor is controlled in a manner to ensure a given minimum elimination of the impurities. The gas and solids are withdrawn from the reactor and passed to a separating means, in which substantially impurity-free solids can be separated from the gas. The aforesaid minimum temperature and said regulated oxygen potential are maintained while the solids are in contact with said gas, and at least a part of the separated solids is returned to the reactor, for controlling the residence time, and an end product is removed from the fluidized bed and/or the separating means. The method is suitably carried out in one stage in a fluidized-bed reactor having a circulatory fluidized bed, although in certain cases the method can be carried out in two stages, in mutually separate reactors.
Patent AU-2975689-A (AU)
Title: A plant for breaking up and recycling of material, particularly roadway material
IPC: E01C19/05
Filed: 1989-02-08
Abstract: Installation for disintegrating and processing material, such as building and road-building material especially of broken-up roads, comprising a first mobile unit which has a travelling mechanism, a feeding hopper, a breaker, a conveyor for the material disintegrated in the breaker as well as drive motors for the travelling mechanism, the breaker and the conveyor, comprising a second mobile unit which has a travelling mechanism, a screening station, a conveyor for the screened material and drive motors for the travelling mechanism, the screening station and the conveyor, and comprising a control device for the simultaneous propulsion of the mobile units at the same distance from one another, the breaker being supported on the travelling mechanism so as to be swivellable about an axis which runs approximately in the longitudinal direction of the first mobile unit, adjustment elements being arranged between the travelling mechanism and the breaker and a control device being provided for adjusting the inclination of the breaker via the adjustment elements. <IMAGE>
Patent AU-2991097-A (AU)
Title: Branched surfactant manufacture
Inventor: CONNOR DANIEL STEDMAN
IPC: C11D1/66
Filed: 1997-04-16
Abstract: Alpha-olefins are dimerized to form branched-chain feedstocks for detersive surfactants.
Patent AU-3056384-A (AU)
Title: Antibacterial quinoline-3-carboxylic acids
Inventor: CHU DANIEL TIM-WO
IPC: C07D405/14
Filed: 1984-07-13
Abstract: Quinoline compounds having the formula: <CHEM> wherein R is an phenyl group or an aromatic heterocyclic group, Z is an aliphatic heterocyclic group or an amine, and R1 is hydrogen or a carboxy-protecting group. The compounds here disclosed have antibacterial properties.
Patent AU-3062892-A (AU)
Title: Cd8 binding domain peptides
IPC: A61P37/06
Filed: 1992-11-03
Abstract: The present invention provides compositions comprising a peptide having between about 7 and about 20 amino acid residues, the peptide being capable of binding a CD8 molecule on a cytolytic T lymphocyte (CTL) precursor and inhibiting differentiation of the CTL precursor to a mature CTL. The peptides have amino acid sequences substantially homologous to a sequence in an  alpha 3 domain of a human Class I MHC molecule. The sequence from the  alpha 3 domain is preferably between residue 220 and residue 235. The peptides typically comprise the sequences DQTQDTE (SEQ. ID No. 1) or EDQTQDTELVETRP (SEQ. ID No. 2).
Patent AU-3189084-A (AU)
Title: Measuring wear of railroad rails
Inventor: JAEGGI HANS P
IPC: G01B7/28
Filed: 1984-08-14
Abstract: In accordance with the present invention, there is provided a chassis adapted for travel along a railroad rail with the chassis having a plurality of bearing points located between the chassis and the rail for supporting the chassis on the rail and for allowing movement of the chassis over the rail. The bearing points are aligned along a reference line and are at least variably spaced on opposite sides of a sensing point mounted on the chassis. At least one bearing point on each side of the sensing point contacts the rail surface as the chassis moves over the rail. A sensing device is provided at the sensing point for continuously sensing the distance between the reference line and the surface of the rail as the chassis travels along the rail. The sensing device has an output which is a function of the sensed distance between the reference line and the rail surface. A device, such as a strip recorder, is responsive to the output of the sensing device to indicate the corrugations and undulations in the rail surface.
Patent AU-3198493-A (AU)
Title: Corrosion inhibitors
IPC: C09D5/00
Filed: 1993-01-22
Abstract: Coating composition comprising:     A) an organic film-forming binder; and B) a corrosion-inhibiting amount of a water-insoluble salt of i) a carboxylic acid having the formula (I): <CHEM> in which a is 0 or an integer ranging from 1 to 5; m and n, independently, are 0 or an integer ranging from 1 to 10; X1 is O, S or -C(R5)(R6) provided that, if m and n are each 0, then X1 is not O or S; R1, R2, R3, R4, R5 and R6 are the same or different and each is hydrogen, C1-C15 alkyl, C2-C15 alkenyl, C3-C12 cycloalkyl, C2-C15 alkyl interrupted by one or more O-, N- or S-atoms, or each is C6-C10 aryl, C7-C12 aralkyl or C7-C12 aralkenyl each optionally substituted by one to five groups R, or any two of R1 and R2, R3 and R4 or R5 and R6 may form a C3-C12 cycloalkyl ring or a C6 aryl ring; and R is halogen, nitro, cyano, CF3, C1-C15 alkyl, C5-C12 cycloalkyl, C2-C15 alkenyl, C1-C15 halogenoalkyl, C1-C12 alkoxy, C1-C12 thioalkyl, C6-C12 aryl, C6-C10 aryloxy, C7-C12 aralkoxy, C7-C12 alkaryl, CO2H, CO2-C1-C12 alkyl in which the alkyl group is optionally interrupted by one or more O-, N- or S-atoms, CO2-C7-C12 alkaryl, CO2-C6-C12-aryl in which the aryl group is optionally substituted with one or more carboxy groups, -C(=O)H, -C(=O)-C1-C12 alkyl in which the alkyl group is optionally interrupted by one or more O-, N- or S-atoms, -C(=O)-C7-C12 alkaryl, -C(=O)-C6-C12 aryl in which the aryl group is optionally substituted with one or more carboxy groups, NH2, NH-C1-C15 alkyl or N(C1-C15 alkyl)2 groups in which the alkyl groups are optionally interrupted by one or more O-, N- or S-atoms, or any two groups R may form a fused aliphatic or C6 aromatic ring; and ii) a base selected from a) a cation of Group Ib, Ila, Ilb, IlIa, lIIb, IVa, lVb, Va, Vla, Vlla or VlIIa of the Periodic Table of Elements, b) an amine of formula II: <CHEM> in which X, Y and Z are the same or different and each is hydrogen, C1-C24 alkyl optionally interrupted by one or more O- or N-atoms, C7-C9 phenylalkyl or C7-C9 alkylphenyl, or two of X, Y and Z, together with the N-atom to which they are attached, forms a 5-, 6- or 7- membered heterocyclic residue which optionally contains one or more further O-, N- or S-atoms, and which is optionally substituted by one or more C1-C4 alkyl, amino, hydroxy, carboxy or C1-C4 carboxyalkyl groups, or two or X, Y and Z represent a double bond connected to a carbon atom and, together with the other one of X, Y and Z, form a heterocyclic ring which optionally contains one or more further O-, N- or S-atoms and may be fused to a phenyl ring, provided that X, Y and Z may not be simultaneously hydrogen; c) a guanidine of formula III: R7-N=C(NH2)2   III in which R7 is hydrogen or C1-C15 alkyl; d) an amidine of formula IV: R7-C(=NH)NH2   IV in which R7 has its previous significance; or e) melamine which is optionally substituted with one or more C1-C15 alkyl groups or phenyl groups.
Patent AU-3391397-A (AU)
Title: Method and apparatus of providing bit count integrity and synchronous data transfer over a channel which does not preserve synchronization
Inventor: GROB MATTHEW S
IPC: H04L7/00
Filed: 1997-06-11
Abstract: Synchronization and bit count integrity of a synchronous data stream is preserved end to end even as it is transmitted via a medium which does not preserve the synchronous nature of the synchronous data stream. A terminal equipment unit produces a constant rate bit stream which is provided to a communications unit. The communications unit produces first, second, and third data frames comprising, respectively, first, second, and third set of bits from the constant rate bit stream and first, second, and third length fields. The first, second, and third data frames are transmitted to a base unit which places the first set of bits from the first frame into a queue. A set of fill bits equal to the maximum number of bits contained in any frame is then placed into the queue. The base unit then determines the number of bits in the second set of bits of the third data frame, based on the first length field value and the third length field value. The base unit overwrites excess fill bits in the queue with the third set of bits. The number of excess fill bits is equal to the difference between the maximum possible number of bits which may be contained in any frame and the number of bits in the second set of bits.
Patent AU-3450593-A (AU)
Title: Pyrroloimidazolyl and imidazopyridinyl substituted 1H-benzimidazole derivatives
Inventor: JANSSEN MARCEL AUGUST CONSTANT
IPC: A61K31/415
Filed: 1993-01-20
Abstract: Pyrroloimidazolyl and imidazopyridinyl substituted 1H &cir& _-benzimidazole derivatives having formula (I) wherein n is 0 or 1; R<1> is hydrogen, nitro, amino, mono- or diC1-6alkyl)amino, halo, C1-6alkyl, hydroxy or C1-6alkyloxy; R<2> is hydrogen; C1-10alkyl; C3-6alkenyl; C3-6alkynyl; C3-7cycloalkyl; phenyl; substituted phenyl; C1-4alkyl substituted with phenyl, substituted phenyl, naphthalenyl, thienyl, furanyl, C1-4alkylfuranyl, C3-7cycloalkyl; and R<3> is hydrogen, C1-8alkyl; C3-7cycloalkyl; hydroxy, amino; C1-6alkyloxy; C1-6alkyloxycarbonylamino; phenyl; C1-4alkyl substituted with phenyl, piperazinyl, 4-(C1-4alkyl)piperazinyl or morpholinyl; each substituted phenyl independently is phenyl substituted with a substituent independently selected from halo, hydroxy, hydroxymethyl, trifluoromethyl, C1-6alkyl, C1-6alkyloxy, C1-6alkyloxycarbonyl, carboxyl, formyl, (hydroxyimino)methyl, cyano, amino, mono- and di(C1-6alkyl)amino and nitro, having sex hormone synthesis inhibiting properties. Compositions containing said compounds of formula (I). Preparations of said compounds and compositions, and use thereof for treating mammals suffering from sex hormone disorders.
Patent AU-3498493-A (AU)
Title: Lubricants for chain belt conveyors and their use
Inventor: STROTHOFF WERNER
IPC: C10N30/16
Filed: 1993-02-22
Abstract: Chain conveyor lubricants, especially for the food industry, which form clear solutions in water and which contain in combinationa) at least one compound corresponding to formula (I): in whichR1 is a saturated or mono- or polyunsaturated, linear or branched alkyl group containing 6 to 22 carbon atoms, which may optionally be substituted by an -OH, -NH2, -NH-, -CO-, halogen or a carboxyl group,R2 is a carboxyl group containing 2 to 7 carbon atoms,M is hydrogen, alkali metal, ammonium, an alkyl group containing 1 to 4 carbon atoms or a benzyl group, andn is an integer of 1 to 6;b) at least one organic carboxylic acid selected from monobasic or polybasic, saturated or mono- or polyunsaturated carboxylic acids containing 2 to 22 carbon atoms; and, optionally,c) at least one of water, additives, and auxiliaries.
Patent AU-3498795-A (AU)
Title: Method of blocking the sec receptor
Inventor: PERLMUTTER DAVID H
IPC: A61P25/28
Filed: 1995-09-07
Abstract: A method is disclosed for blocking the SEC receptor and also inhibiting the neurotoxic effects of amyloid- beta  protein by treating SEC receptor-bearing cells with a synthetic inhibitor peptide, e.g. peptide PB145.
Patent AU-3795089-A (AU)
Title: Method and apparatus for manufacturing flake graphite
IPC: C01B31/04
Filed: 1989-07-10
Abstract: In the manufacture of flake graphite, coal is added to a metal melt and is partly burned using oxygen in order to heat the melt and is partly dissolved in the melt to raise the carbon content of the metal. Thereafter the melt is cooled so that flake graphite crystallizes out. To improve the solution of the coal in the melt, the coal is added by injecting pulverized coal directly into the melt beneath the surface of the melt and the pulverized coal is burned in the melt by the oxygen. Apparatus for carrying out the method having at least one vessel (1,2) for holding a metal melt (15), means (26) for injecting pulverized coal directly into the metal melt, means (26) for introducing oxygen into the melt, means (9) for cooling the melt and means (31,34) for separating flake graphite from the melt.
Patent AU-3823399-A (AU)
Title: Immunodiagnostic reagent for the detection of maedi-visna virus and caev infection
Inventor: GONZALEZ LORENZO
IPC: G01N33/569
Filed: 1999-04-26
Abstract: The current invention relates to a biotinylated peptide represented by the following formula:     ÄB1 -L1Ü - (a) - CWHYX9X10YC- (b) - ÄL2- B2Ü (SEQ ID NO 83) wherein B represents a biotinyl moiety and L represents an amide bond or an amino acid linker sequence containing from 1 to 5 amino acid residues, with either ÄB1 -L1Ü or ÄL2 -B2Ü present or both, and wherein (a) represents from none to the maximum number of contiguous amino acids located from position 1 to position 4 in the sequence represented by SEQ ID NO 12, and wherein (b) represents from none to the maximum number of contiguous amino acids located from position 13 to position 18 in the sequence represented by SEQ ID NO 12.
Patent AU-3916493-A (AU)
Title: Fast response test panel
Inventor: LAWRENCE PAUL J
IPC: G01N33/52
Filed: 1993-03-10
Abstract: A dry test panel for the testing of samples such as undiluted bodily fluid specimens is disclosed. The panel contains all reagents and components necessary to achieve a visible indication of the presence or absence of a suspect analyte in the sample, and preferred embodiments contain positive and negative controls as well. The device contains an internal chamber into which the specimen is introduced, and which contains all materials necessary for the reactions which produce a color change which is visible on the outer surface of the device. The materials are positioned in the chamber in such a manner that they are activated only when the chamber is filled with the specimen, and the color indicator is concentrated in a thin lamina immediately adjacent to a light-transmitting wall of the device so that a detectable color change occurs in a short period of time to produce a sensitive and yet fast test.
Patent AU-4343296-A (AU)
Title: Process for the fermentative preparation of clavam derivatives whereby the levels of ammonia and urea in the fermentation medium are kept low
Inventor: VALENTINE BRIAN PETER
IPC: C07D503/00
Filed: 1995-12-07
Abstract: Improved methods for the preparation of clavams by fermentation of a clavam-producing organism in a suitable medium wherein the ammonium levels are kept low so as to avoid repression of enzymes, particularly urease, are disclosed.
Patent AU-4461697-A (AU)
Title: Marking of electronic documents in order to expose unauthorized publication
Inventor: HIPPELAINEN LASSI
IPC: G06F1/00
Filed: 1997-09-29
Abstract: A method of marking information to be produced in order to expose unauthorized copying. In the method, a user identifier is defined, a source file containing a substantial part of the information produced is created, and a different target file is created for each user on the basis of the source file and the user identifier. In the invention, several predefined modification rules are stored in a file in order to modify the information contained in the source file. Using a digital processor, a sequence of modification keys is generated on the basis of the user identifier, the locations of the source file to be modified are defined, and modifications are made in these locations, determining the nature and/or position of the modifications on the basis of the predefined modification rules and modification keys. From the content of the target file delivered to the user, it is possible to conclude a user-specific identifier and thereby the person responsible for the unauthorized copy.
Patent AU-4553700-A (AU)
Title: Substitution infusion fluid and citrate anticoagulation
Inventor: CHANG PE CHOU
IPC: A61M1/36
Filed: 2000-04-20
Abstract: The invention relates to a substitution infusion fluid for hemofiltration of a specific composition. The use of said substitution infusion fluid significantly reduces the risk of the occurrence of abnormalities in a patient undergoing pure hemofiltration. The invention also relates to process for pure hemofiltration of blood wherein said substitution infusion fluid is used. The invention also relates to a matching citrate anticoagulation fluid of a specific composition. The invention also relates to a process for pure hemofiltration of blood wherein said substitution infusion fluid is used in combination with said citrate anticoagulation fluid. The use of said substitution infusion fluid in combination with said citrate anticoagulation fluid significantly further reduces the risk of the occurrence of abnormalities in a patient undergoing pure hemofiltration.
Patent AU-4621299-A (AU)
Title: Rigid container for transporting a bag containing bio-pharmaceutical fluid products
Inventor: VALLOT BERNARD
IPC: B65D90/02
Filed: 1999-07-01
Abstract: A rigid container for transporting flexible sachets of bio-pharmaceutical fluid having a volume of 50 liters or more has a bottom wall and one or more lateral walls. At the top it has a contention plate for the sachet adjustable in height to compress the sachet.
Patent AU-4678696-A (AU)
Title: A method for repairing a local damage
Inventor: HAANDEL JOHANNES HENRICUS MARI
IPC: B29C73/02
Filed: 1996-01-19
Abstract: A method for repairing a locally damaged, dented surface of a wall, whereby the surface is provided with a relief, as well as a wall comprising a locally repaired surface, which has been repaired by using the method below. A mould comprising an impression of the relief of an undamaged part of the surface is made, the dented surface is filled with a filler, after which the impression on the mould is pressed into the filling material, as a result of which a relief corresponding with the original relief is formed in the filling material.
Patent AU-4790990-A (AU)
Title: Non-staining lubrication of laundry iron soles
Inventor: MATTESKY HENRY
IPC: D06F75/38
Filed: 1990-01-11
Abstract: A laundry iron lubricating means is provided comprising a fabric substrate having a coating containing a lubrication agent. In the operation of the device, the hot laundry iron is run over the coated fabric with normal pressure. The lubrication provided by a single pass reduces iron drag by 20 to 50%, adequate for the ironing of at least one large garment without need for a second pass. The greater the sole temperature of the iron, the greater the drag reduction.
Patent AU-4950896-A (AU)
Title: Explosive compositions
Inventor: COUPLAND KEITH
IPC: C09K23/00
Filed: 1996-03-11
Abstract: PCT No. PCT/GB96/00565 Sec. 371 Date Feb. 12, 1997 Sec. 102(e) Date Feb. 12, 1997 PCT Filed Mar. 11, 1996 PCT Pub. No. WO96/28436 PCT Pub. Date Sep. 19, 1996   <IMAGE>  (I)   <IMAGE>  (II)  Gamma and delta lactones of formulae (I and 11) are used as emulsifiers in explosive compositions comprising a continuous organic phase and a discontinuous aqueous phase containing an oxygen-supplying compound. In the formulae, R is hydrocarbyl, R* is hydrogen, methyl or another hydrocarbyl, and Q is an amide, ammonium salt or ester functionality.
Patent AU-5035201-A (AU)
Title: Recombinant influenza a viruses
Inventor: FERKO BORIS
IPC: A61K39/00
Filed: 2001-03-02
Abstract: The invention relates to a recombinant NS gene of an influenza A virus comprising a functional RNA binding domain and a gene sequence modification after nucleotide position 400 of the NS1 gene segment, counted on the basis of influenza A/PR/8/34 Virus, wherein the modification bars transcription of the remaining portion of the NS1 gene segment. It further relates to embodiments, wherein the modification comprises deletions, insertions, or a shift of the open reading frame, and particularly to constructs comprising an insertion of an autocleavage site 2A, the nef gene from HIV-1 or the sequence encoding the ELDKWA-epitope of gp4l of HIV-1. The invention also relates to influenza virus transfectants that contain the modified NS gene and have an IFN inducing phenotype but which may or may not be sensitive towards IFN. The invention also relates to vaccines comprising such a chimeric virus.
Patent AU-5096299-A (AU)
Title: Fluid transfer and diagnostic system for treating the inner ear
Inventor: ARENBERG IRVING K
IPC: A61F11/00
Filed: 1999-07-12
Abstract: An apparatus for delivering fluid materials into and out of the inner ear via the round window membrane. A fluid transfer conduit is provided which includes one or more passageways therethrough which may have a semipermeable membrane associated therewith to control fluid flow. Attached to the conduit is an inflatable bladder sized for insertion within the round window niche. When inflated, the bladder engages the internal side wall of the niche, thereby securing the bladder and part of the conduit within the niche. The conduit can then transfer fluids to and from the niche and the fluid-permeable round window membrane therein. Bladder inflation may be achieved through one of the passageways within the conduit which can deliver an inflation fluid into the bladder. Also, the conduit may include an elongate conductive diagnostic member for transferring electrical potentials to and from the inner ear.
Patent AU-5103890-A (AU)
Title: Single-package agricultural formulations combining immediate and time-delayed delivery
Inventor: RODSON MARIUS
IPC: A01N25/28
Filed: 1990-01-31
Abstract: Microcapsule formulations are combined with emulsions or particle dispersions in a single-package formulation which is storage-stable and provides substantially the full efficacy of each of the two forms as if applied individually. The single-package formulation is suspension having two dispersed phases-the first being an active species encapsulated in a shell of inert polymeric diffusion-limiting material (i.e., a microcapsule), and the second being an active species in water-insoluble form with no diffusion-limiting barrier at its surface. An appropriate suspension system is included to prevent the dispersed phases from agglomerating within themselves and with each other. The invention is useful in combining two different active ingredients as well as in combining immediate-delivery and delayed-delivery forms of the same active ingredient. The invention may for example involve combining a biocide with an activity modifier such as a safener, with the effect of lowering the needed amount of one or the other by removing it to a separate phase. In certain cases, a unique combination of surface-active agents maintains the phases in suspension.